Study Stopped
Investigator did not start the project in time; study team decided it was not feasible to begin study as resident was soon graduating. No patients enrolled.
Use of a Perineometer to Assess Pelvic Muscle Tone
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to establish the range of pelvic floor pressure in groups of women, including women with and without pelvic pain, and compare the change in perineometer measurements between rest and maximum pelvic floor contraction in women with and without pelvic pain. Purpose is also to determine whether resting pelvic floor perineometer measurements correlate with the severity of pain symptoms in women with chronic pelvic pain.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2015
CompletedFirst Posted
Study publicly available on registry
January 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedJune 20, 2016
June 1, 2016
January 20, 2015
June 17, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
measurement of pelvic pressure in the two groups
using the peritron device at rest and maximum squeeze
1 day
Secondary Outcomes (2)
Brinks score
1 day
Pelvic pain score
1 day
Study Arms (2)
Women with Chronic Pelvic Pain
Use of perineometer to measure pelvic resting tone and contraction in women with chronic pelvic pain and determine if resting tone correlates with severity of pain.
Women without Chronic Pelvic Pain
Use of perineometer to measure pelvic resting tone and contraction in women without chronic pelvic pain
Eligibility Criteria
A group of adult women, seen in an outpatient urogynecology or minimally invasive gynecology clinic, including women with and without pelvic pain.
You may qualify if:
- being seen in the Duke Urogynecology or Minimally Invasive Gynecology Clinics
You may not qualify if:
- botulinum toxin A injection into bladder or pelvic floor musculature within the prior 9 months
- history of GYN or GU malignancy
- chronic use of muscle relaxants
- exam findings that would preclude the ability of the woman to retain the Peritron device (e.g. narrowed introitus or stage III/IV prolapse).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nazema Siddiqui, MD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2015
First Posted
January 26, 2015
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
June 20, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will not share
study withdrawn